Type de document
Résultats 1-20 de 751
-
18f-fdg positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
Arthritis Research & Therapy, 06-03-2021, 23, 76Article dans une revue scientifiquetexte intégral -
4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors
MedChemComm, 20-07-2015, 2, 65-72Article dans une revue scientifique -
4-Oxo-1,4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands Part 2: Discovery of New Agonists Endowed with Protective Effect Against Experimental Colitis
J. Med. Chem., 20-07-2015, 55, 8948-8952Article dans une revue scientifique -
4-Oxo-1,4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands: Structural Insights into the Design of a Novel Inverse Agonist Series
J. Med. Chem., 20-07-2015, 53, 7918-7931Article dans une revue scientifique -
(90)Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow-Up of 7.3 Years From the International, Randomized, Phase III First-Line Indolent Trial
J. Clin. Oncol., 11-07-2015, 31, 1977-+Article dans une revue scientifique -
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma
Ann. Oncol., 11-07-2015, 23, 2687-2695Article dans une revue scientifique -
A chemometric approach to elucidate the parameter impact in the hyphenation of evaporative light scattering detector to supercritical fluid chromatography
J. Chromatogr. A, 15-03-2016, 1333, 124-133Article dans une revue scientifique -
A Dose-Escalation Study of SAR3419, an Anti-CD19 Antibody Maytansinoid Conjugate, Administered by Intravenous Infusion Once Weekly in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Clin. Cancer Res., 11-07-2015, 20, 213-220Article dans une revue scientifique -
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the \"REal world dAta in LYmphoma and survival in adults\" (REALYSA) cohort.
BMC Public Health, 04-03-2021, 21, 432Article dans une revue scientifique -
A method for the simultaneous determination of chlorogenic acid and sesquiterpene lactone content in industrial chicory root foodstuffs.
ScientificWorldJournal, 20-07-2015, 2014, 583180Article dans une revue scientifique -
A multivariate approach for the determination of isoelectric point of human carbonic anhydrase isoforms by capillary isoelectric focusing
Electrophoresis, 11-07-2015, 32, 2857-2866Article dans une revue scientifique -
A new cernuane-type alkaloid from Lycopodium cernuum
Biochem. Syst. Ecol., 11-07-2015, 45, 188-190Article dans une revue scientifique -
A new species of ljuhya, I. antillana, from the French West Indies
Mycotaxon, 20-07-2015, 113, 443-447Article dans une revue scientifique -
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid (R)) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial
Eur. J. Cancer, 11-07-2015, 49, 2869-2876Article dans une revue scientifique -
A severe acute hepatitis related to sevoflurane
Anesth. Reanim., 06-04-2019, 2, 238-242Article dans une revue scientifique -
A validated micellar electrokinetic chromatography method for the quantitation of dexamethasone, ondansetron and aprepitant, antiemetic drugs, in organogel
J. Pharm. Biomed. Anal., 11-07-2015, 86, 40-48Article dans une revue scientifique -
The A2B trial, antibiotic prophylaxis for excision-graft surgery in burn patients: a multicenter randomized double-blind study
Trials, BioMed Central, 25-11-2020, 21, 973Article dans une revue scientifiquetexte intégral -
ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study.
Clinical Lymphoma & Myeloma & Leukemia, Elsevier, 29-09-2022, 22 (Suppl.2), S358-S359Article dans une revue scientifique -
Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma
Br. J. Haematol., 2015, 170, 285-287Article dans une revue scientifique -
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Lancet (London, England), 2017Article dans une revue scientifique